Ebronucimab (Anti-PCSK9)
Ebronucimab (Anti-PCSK9) is a fully human immunoglobulin G1 (IgG1) monoclonal antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used to treat hyperlipidemia. MW : 144.76 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2843 |
| Sku # | A2843-1mg*5 |
| Pricing | 1mg*5, $1690.00 |